Vimarsana
Biggest News Aggregation in the World

Liberalised Pricing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Liberalised Pricing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Liberalised Pricing Today - Breaking & Trending Today

WHO decision on Covaxin nod extended to next week - Vimarsana News

WHO decision on Covaxin nod extended to next week

The WHO has approved COVID-19 vaccines by Pfizer-BioNTech, AstraZeneca, Johnson and Johnson, Moderna and Sinopharm till date.

Source: newsx.com
WHO likely to decide on Covaxin emergency usage by next week - Vimarsana News

WHO likely to decide on Covaxin emergency usage by next week

WHO likely to decide on Covaxin emergency usage by next week - The approval for the emergency use authorization for Covaxin will most likely be issued by WHO in the next week, as per reports.

WHO to take decision on Covaxin next week - Vimarsana News

WHO to take decision on Covaxin next week

"WHO and an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin," tweeted the world health body

Source: india.com
WHO decision on Covaxin nod extended to next week - Vimarsana News

WHO decision on Covaxin nod extended to next week

Geneva [Switzerland], October 5 (ANI): World Health Organisation (WHO) has extended giving the emergency use authorization for Hyderabad-based Bharat Biotechs COVID-19 vaccine Covaxin to next week.

Source: sify.com
WHO decision on Covaxin nod extended to next week - Vimarsana News

WHO decision on Covaxin nod extended to next week

World Health Organisation (WHO) has extended giving the emergency use authorization for Hyderabad-based Bharat Biotech COVID-19 vaccine Covaxin to next week.